An aneurysm is a bulge in a blood vessel wall. When it ruptures, it bleeds into or around the brain. Subarachnoid hemorrhage — bleeding into the space surrounding the brain — kills roughly 40% of people within the first thirty days. Of those who survive, another 30-40% end up with permanent disability. The warning signs, on the rare occasion they even show up, get dismissed constantly. The condition tends to stay invisible right up until it isn’t.
Most of what the public believes about aneurysms is wrong, oversimplified, or dangerously incomplete. Pick one.
This piece covers what aneurysms actually are at a structural level, who’s at risk, what the warning signs are, what “sentinel headache” means and why it matters, what the evidence says about treatment decisions, and how to think about family risk in a way that produces actual action instead of just anxiety. Paul’s story is not unusual. What Diane learned in the months afterward is the kind of information that saves lives — including, possibly, the reader’s own.
The Anatomy of an Aneurysm: Understanding What’s Actually Happening
Blood vessels aren’t simple tubes, whatever the diagrams in a middle school textbook suggest. They’re layered structures: the tunica intima, an inner lining of endothelial cells; the tunica media, a middle layer of smooth muscle and elastic fibers that gives arteries their strength and flexibility; and the tunica adventitia, an outer connective tissue layer. An aneurysm forms when that wall weakens somewhere and starts bulging outward under the constant pressure of arterial blood flow.
The most common type of intracranial aneurysm is the saccular, or berry, aneurysm — a round bulge forming at a junction point where arteries branch. Branch points take more mechanical stress than a straight stretch of artery, because blood flow changes direction there and kicks up turbulence. The internal elastic lamina, the layer mainly responsible for resisting dilation, also happens to be thinner right at those junctions. Bad luck of geometry.
A 2012 paper in Stroke by Rinkel and colleagues estimated that approximately 3.2% of the adult population harbors an unruptured intracranial aneurysm — roughly one in thirty people.
Fusiform aneurysms are a less common type, involving dilation around the entire circumference of a vessel segment rather than a discrete bulge on one side. These show up more often with atherosclerosis and tend to occur in larger vessels. Dissecting aneurysms are a different mechanism entirely — a tear in the vessel wall lets blood track between layers, which can happen acutely after trauma or spontaneously in conditions like fibromuscular dysplasia.
The most common locations for intracranial saccular aneurysms: the anterior communicating artery (roughly 30-35% of cases), the middle cerebral artery bifurcation (about 20%), the posterior communicating artery origin off the internal carotid (15-20%), and the basilar artery apex (about 10%). These locations line up precisely with the major branch points in the cerebral arterial circulation. Not a coincidence.
Size matters enormously for rupture risk, though the relationship isn’t a clean threshold the way people sometimes assume. The International Study of Unruptured Intracranial Aneurysms — ISUIA, one of the largest datasets on the question — found that aneurysms under 7mm in the anterior circulation carried a five-year rupture risk of approximately 0% in patients with no prior subarachnoid hemorrhage. Aneurysms 7-12mm carried a 2.6% five-year risk, 13-24mm carried 14.5%, and 25mm or larger carried 40%.
Posterior circulation aneurysms — basilar tip and posterior fossa — had higher rupture rates at every size category.
Who Gets Aneurysms: Risk Factors and Genetics
Intracranial aneurysms don’t form at random. There are clear risk factors, some modifiable and some not, and it’s the intersection of genetic predisposition with environmental triggers that determines individual risk — which is exactly why personalized assessment actually means something here.
Hypertension is the single most powerful modifiable risk factor, by a wide margin. Elevated blood pressure chronically stresses the vessel wall, accelerates degradation of the elastic lamina, and drives remodeling changes that weaken the artery over time. Population studies consistently show hypertension doubling to tripling the risk of both aneurysm formation and rupture compared to normotensive people. The mechanism isn’t mysterious: higher wall stress at branch points speeds up the same degradation that leads to aneurysm formation in the first place.
Cigarette smoking is the second major modifiable risk factor. A large meta-analysis published in Stroke found current smokers carried approximately 3.1 times the risk of subarachnoid hemorrhage compared to non-smokers, and former smokers carried 1.7 times the risk — still elevated, even after quitting. Smoking drives aneurysm formation through several mechanisms: it reduces alpha-1 antitrypsin activity, releasing elastase that destroys the elastic lamina, it raises oxidative stress on vessel walls, and it promotes the kind of systemic inflammatory change that weakens vascular tissue generally.
Paul had smoked for twelve years before quitting at forty. The damage to his vascular walls may well have predated his quit date by a decade. Quitting doesn’t erase the ledger.
Genetic factors matter a great deal. First-degree relatives of patients with subarachnoid hemorrhage carry roughly four times the general population’s risk of harboring an intracranial aneurysm themselves. Specific hereditary conditions tied to elevated aneurysm risk include autosomal dominant polycystic kidney disease (ADPKD), Ehlers-Danlos syndrome type IV, Marfan syndrome, neurofibromatosis type 1, and hereditary hemorrhagic telangiectasia. In families with ADPKD, intracranial aneurysm prevalence runs around 8%, against the 3.2% general population rate.
Genome-wide association studies have turned up multiple genetic loci tied to intracranial aneurysm susceptibility. A 2020 Nature Genetics study identified 21 risk loci, many sitting in genes related to collagen metabolism, elastin structure, and smooth muscle cell biology. That genetic architecture fits with aneurysms being, at bottom, a disease of arterial wall structure — genetic variants that subtly compromise structural integrity, combined with hemodynamic stress and environmental triggers, decide who ends up most vulnerable.
Sex is also a factor. Women show a higher prevalence of intracranial aneurysms than men, roughly 1.6 to 1, and the gap widens with age, particularly after menopause. Estrogen appears to protect arterial wall structure — it promotes collagen synthesis and holds back inflammatory remodeling. The sharp uptick in risk after menopause points to hormonal effects on vascular biology that are clinically real, not incidental.
Oral contraceptive use, somewhat counterintuitively, may also raise risk in younger women, though the absolute increase is small.
The Sentinel Headache: The Warning Sign That Gets Ignored
Here’s the single most important piece of information in this article, and the one most likely to actually save a life. Before many major subarachnoid hemorrhages, there’s a warning bleed — a minor leak from the aneurysm producing a sudden, severe headache without the devastating neurological damage of a full rupture. That’s the sentinel headache. Patients who recognize it and get emergency evaluation in time can have the aneurysm treated before catastrophic rupture happens.
The sentinel headache is classically “the worst headache of my life” — sudden, severe, and qualitatively unlike anything the patient has experienced before. It can come with nausea, neck stiffness, or light sensitivity, or none of those at all — just a sudden, explosive headache that peaks within sixty seconds. Neurologists and emergency physicians use the term “thunderclap headache” for this pattern, and it’s a term worth knowing.
The tragedy is that sentinel headaches get dismissed constantly — by patients themselves, who chalk it up to stress or dehydration or a bad migraine, and sometimes by providers who see headache complaints all day and don’t always push the workup as hard as they should. A landmark study by Leblanc and colleagues found that among patients who showed up in the ER with sentinel headaches and got sent home without proper evaluation, most had a catastrophic hemorrhage within days to weeks.
Multiple studies put the number at 20-50% of subarachnoid hemorrhage patients having had a sentinel headache in the days to weeks before the major bleed — one that went unrecognized or wasn’t properly evaluated.
Standard emergency workup for suspected subarachnoid hemorrhage: CT scan of the head without contrast, then lumbar puncture if the CT comes back negative. CT is highly sensitive for subarachnoid blood in the first six hours — about 98% sensitivity — but that sensitivity drops fast after that. Blood in the subarachnoid space gets reabsorbed, and CT can look normal within 24-48 hours even after a genuine warning bleed.
Which is exactly why a lumbar puncture — checking for blood or xanthochromia, the yellow tint from blood breakdown products, in the spinal fluid — is necessary when the CT is negative but the clinical suspicion is still there.
The worst headache of your life is a medical emergency until proven otherwise. That sentence, internalized and acted upon, is the difference between a diagnosis that allows treatment and a catastrophe that doesn’t. Every minute matters. Call 911.
A sudden, severe headache — the worst of a person’s life, particularly if it’s unlike their usual headaches, if it hit suddenly and peaked within seconds to minutes, if it comes with neck stiffness or light sensitivity — is a medical emergency. Get to an emergency room immediately. Don’t wait to see if it passes. Don’t call the primary care office for next week’s slot.
This is the one rule about aneurysms that most directly translates into saved lives.
The Full Rupture: What Happens and Why Outcomes Vary So Dramatically
The 30-day mortality rate for subarachnoid hemorrhage runs approximately 40-50% across most large case series. A significant share of deaths happen before the patient ever reaches a hospital — roughly 15% of subarachnoid hemorrhage deaths occur before emergency services arrive. Of those who make it to hospital admission, roughly 40-50% will die or end up with permanent disability within thirty days. That stark math is exactly why prevention and early recognition carry so much weight.
Initial severity gets measured with the Hunt and Hess scale, Grade 1 through 5, or the World Federation of Neurological Surgeons scale — both correlate strongly with outcomes. Grade 1 patients, mild headache with no neurological deficit, have mortality rates around 10-15%. Grade 5 patients, deep coma with decerebrate posturing, have mortality above 70-80%.
The clinical grade at admission is the single strongest predictor of outcome — which is exactly why catching and treating warning bleeds early, before catastrophic hemorrhage, matters as much as it does.
Secondary complications drive a large share of the morbidity and mortality after the initial bleed. Cerebral vasospasm — narrowing of cerebral arteries in reaction to blood products in the subarachnoid space — shows up in roughly 70% of patients and causes delayed neurological deterioration in 30-40% of them, typically between days 3 and 14 after the bleed. Hydrocephalus, fluid buildup in the brain, occurs in 20-30% of patients and often requires a ventricular drain.
Rebleeding, before the aneurysm gets secured, carries mortality of 60-80% and was historically the deadliest complication of all — before modern surgical and endovascular techniques made rapid treatment possible.
Unruptured Aneurysms: The Incidental Finding Dilemma
A growing clinical challenge: the incidental discovery of unruptured aneurysms, found on MRI or CT ordered for something else entirely — a headache workup, a trauma scan, a vertigo evaluation. The spread of high-resolution brain imaging has sharply increased the number of people who now know about an aneurysm they never had a symptom for, which creates a decision-making problem that neurosurgeons and patients have to work through together.
The core question: for a given unruptured aneurysm in a given patient, does the risk of treating it exceed the risk of watching it? Not a simple calculation. Treatment — surgical clipping or endovascular coiling — carries its own risk of stroke, neurological deficit, and death. Watchful waiting carries the cumulative risk of rupture over whatever years remain in the patient’s life.
The right call depends on aneurysm size and location, patient age, comorbidities, aneurysm shape, and how much risk the patient is actually willing to live with.
The ISUIA data and the analyses that followed it have tried to pin down treatment thresholds. For small aneurysms — under 5-7mm — in the anterior circulation, in otherwise healthy patients with no prior subarachnoid hemorrhage, annual rupture risk runs low enough (about 0.1-0.5% per year for the smallest ones) that many neurosurgeons recommend surveillance over immediate treatment.
For larger aneurysms, posterior circulation aneurysms, aneurysms in patients carrying specific risk factors — prior SAH, family history, hypertension, smoking — or aneurysms showing growth on surveillance imaging, treatment is generally the recommendation.
Shape matters too, beyond size alone. Irregularity of the aneurysm wall — daughter sacs or lobulations visible on imaging — correlates with higher rupture risk independent of size. A 2015 JAMA Neurology study found irregular aneurysm shape carried roughly 2-3 times higher rupture risk compared to smooth aneurysms of the same size. Thought to reflect areas of focal weakness in the wall.
Deciding whether to treat or observe an incidental aneurysm is one of the more detailed calls in neurovascular medicine. Ideally it happens in consultation with an experienced cerebrovascular neurosurgeon or interventional neuroradiologist, using shared decision-making that weighs the patient’s values and risk tolerance — not just the numbers in a table.
Treatment Options: Clipping vs. Coiling and Beyond
When an aneurysm gets treated — after rupture, or prophylactically for an unruptured one — two main approaches exist: surgical clipping and endovascular coiling. A newer third category has emerged in recent years too, flow diverters and intrasaccular devices, expanding what’s possible for complex anatomy.
Surgical clipping means opening the skull — craniotomy — working between brain structures to reach the aneurysm, and placing a small metal clip across its neck to shut it out of the circulation. The clip stays in permanently, essentially re-engineering the vessel’s anatomy. Clipping has been performed since the 1930s, and its long-term outcome profile is well understood. Complete occlusion rates run high, roughly 85-95%, and durability is excellent — clipped aneurysms rarely come back.
Endovascular coiling, developed in the early 1990s, threads a catheter from the groin up through the blood vessels to the aneurysm, then fills the sac with small metal coils that promote clotting and gradually exclude it from the circulation. The landmark ISAT trial — the International Subarachnoid Aneurysm Trial — compared clipping and coiling for ruptured aneurysms and found coiling associated with better outcomes at one year: 23% dead or dependent versus 31% for clipping.
That result shifted practice significantly toward coiling for suitable ruptured aneurysms. Coiling does carry higher rates of incomplete occlusion and long-term recurrence than clipping, though, which means more frequent surveillance imaging down the line.
Flow diverters — the Pipeline Embolization Device specifically — work by placing a densely woven stent across the aneurysm neck in the parent artery, redirecting blood flow away from the aneurysm and promoting gradual thrombosis of the sac. They’ve expanded treatment options for large and giant aneurysms with wide necks that standard coiling struggles with. WEB devices, Woven EndoBridge, sit inside the aneurysm itself, forming an intra-saccular mesh that promotes occlusion without any coils at all.
Which approach gets used depends on aneurysm anatomy, location, patient factors, and institutional expertise. Modern cerebrovascular centers run multidisciplinary case review with both neurosurgeons and interventional neuroradiologists to land on the right approach for each patient. For ruptured aneurysms needing emergency treatment, anatomy and local expertise usually drive the decision. For unruptured aneurysms treated electively, there’s more room for deliberation.
Screening: Who Should Be Evaluated and How
The clearest indication for screening is family history. If two or more first-degree relatives have had subarachnoid hemorrhage or a known intracranial aneurysm, the remaining first-degree relatives carry roughly a 4-fold elevated risk. Multiple neurovascular guidelines recommend offering MR angiography (MRA) to anyone with two or more affected first-degree relatives. Some centers extend screening to those with a single affected relative plus other risk factors — hypertension, smoking.
ADPKD patients carry an 8% prevalence of intracranial aneurysms and are generally recommended for screening, particularly with a family history of aneurysm or prior subarachnoid hemorrhage. Guidelines vary here — some recommend universal screening in ADPKD, others reserve it for those with additional risk factors or family history.
The preferred screening modality is MR angiography without contrast for most patients — no radiation, no contrast dye risk. CT angiography is an alternative with slightly higher sensitivity for very small aneurysms, but it comes with radiation exposure. Digital subtraction angiography, the gold standard for characterizing an aneurysm, is invasive — roughly 0.5% neurological complication risk — and typically reserved for treatment planning rather than screening.
MRA has its limits. Sensitivity for aneurysms smaller than 3-4mm is reduced compared to DSA or CTA, though those very small aneurysms carry such low rupture risk to begin with that the limitation matters less clinically than it might sound. MRA at 3-Tesla has better resolution than 1.5-Tesla and is preferred where available. If a screening MRA comes back negative, repeat screening every 5-7 years is a reasonable approach in high-risk individuals, since aneurysms can form new over time.
Risk Factor Modification: What You Can Actually Control
Genetics can’t be changed. Risk of aneurysm formation, growth, and rupture, though, can be substantially reduced through modifiable risk factor management — and this isn’t a minor point. Population attributable risk calculations suggest hypertension and smoking together account for most of the modifiable risk for subarachnoid hemorrhage. Addressing those two aggressively is the single most evidence-based thing a high-risk person can do beyond surveillance.
Blood pressure control is the most important intervention on the list. The target for patients with known aneurysms or high risk is generally a systolic reading below 130 mmHg, consistent with ACC/AHA hypertension guidelines. The mechanism is direct: lower blood pressure means less mechanical stress on the aneurysm wall and its branch points, slowing the remodeling and degradation that lets aneurysms form and grow in the first place.
Multiple studies have documented that better blood pressure control tracks with lower aneurysm growth rates and lower rupture rates.
Smoking cessation cuts risk substantially, but not instantly. That 3.1-fold increased rupture risk in current smokers versus never-smokers doesn’t fade quickly — former smokers carry elevated risk for years after quitting, though the risk does decline the longer the person stays quit. Every smoke-free year chips away at the residual risk. Pharmacological cessation aids — varenicline, bupropion, nicotine replacement — meaningfully improve long-term quit rates and are worth considering for anyone struggling to stop.
Cocaine and sympathomimetic drugs carry a strong association with aneurysm rupture. Multiple case series document rupture in the context of cocaine use, likely through acute hypertensive surges combined with direct vasotoxic effects. This is a risk factor that doesn’t get discussed nearly enough — physicians should be asking about cocaine use in young patients who show up with subarachnoid hemorrhage.
Heavy alcohol use is tied to both aneurysm formation and rupture. A meta-analysis found heavy drinkers — more than three drinks daily — carried roughly double the subarachnoid hemorrhage risk of non-drinkers. The mechanisms include alcohol’s hypertensive effects, hemostatic changes, and direct effects on the vessel wall. Moderate drinking showed a smaller but still elevated risk. This is exactly the territory where the “but red wine is healthy” oversimplification can do real harm to someone at genuine high risk.
Physical exertion and acute emotional stress can trigger rupture in a susceptible aneurysm — studies have documented higher rates of SAH during Valsalva maneuvers, sex, heavy lifting, and acute anger. For patients with a known unruptured aneurysm, that doesn’t mean cutting out physical activity entirely (exercise still carries real cardiovascular benefit), but it does argue for skipping extreme exertional activities and managing blood pressure aggressively during anything that causes significant acute spikes.
Aortic Aneurysms: A Separate but Related Threat
This article has focused mostly on intracranial aneurysms, but aortic aneurysms deserve their own mention — they’re more common, more often asymptomatic right up until a catastrophic rupture, and they have a clear evidence base for screening that still isn’t universally followed. Abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) are distinct but related risks that share some of the same risk factors as intracranial aneurysms.
AAA prevalence runs approximately 4-8% in men over 65, dropping to roughly 1% in women. The U.S. Preventive Services Task Force recommends a one-time ultrasound screening for AAA in men aged 65-75 who have ever smoked — the recommendation for non-smoking men and for women is less clear-cut based on current evidence. The screening ultrasound takes fifteen minutes, costs relatively little, and catches aneurysms before rupture in most cases when done at the recommended age.
Despite that clear recommendation, screening rates stay low. Studies have found fewer than 30% of eligible men actually get AAA screening. That’s a genuine public health failure — AAA rupture carries a mortality rate around 80%, while elective repair of an identified AAA has mortality below 1% at experienced centers. Catching an AAA before it ruptures is one of medicine’s clearest screening success stories, when it actually gets implemented.
Thoracic aortic aneurysms are more strongly tied to genetic conditions — Marfan syndrome, Loeys-Dietz syndrome, bicuspid aortic valve — and familial forms without those named syndromes are getting recognized more often now too. Anyone with a family history of thoracic aortic disease or a known connective tissue disorder should be getting periodic imaging surveillance.
Living With a Known Aneurysm: Practical Guidance
Follow-up surveillance imaging schedules vary with aneurysm size and risk profile. For small, stable aneurysms — under 5mm — imaging every 1-2 years for the first several years to confirm stability, then less often once stability is established, is a common approach. Larger aneurysms or ones with concerning features may need more frequent surveillance. Any perceived change in symptoms — new headaches, vision changes, facial pain — warrants prompt medical evaluation, scheduled surveillance timeline or not.
Home blood pressure monitoring is genuinely valuable for patients managing aneurysm risk. Consumer monitors are accurate enough for home use, and tracking trends over time allows earlier detection and treatment of elevations. Target blood pressure should be discussed with a vascular neurologist or neurosurgeon based on individual circumstances, but keeping systolic consistently under 130 mmHg is a reasonable general target.
Activity restrictions for patients with unruptured aneurysms aren’t universally agreed on. Most practitioners allow regular aerobic exercise and normal daily activity. High-intensity activities that cause extreme blood pressure spikes — powerlifting, vigorous straining, extreme sports — may warrant an individual conversation. Sexual activity generally isn’t restricted. The goal is overall cardiovascular health, which requires physical activity, balanced against avoiding extreme acute hemodynamic stress on a vulnerable vessel.
Psychological support genuinely matters here. Rates of anxiety and depression run higher in patients with incidentally discovered unruptured aneurysms, and those mental health effects can themselves elevate blood pressure and worsen overall health — a feedback loop worth naming. Support groups (the Brain Aneurysm Foundation provides resources), individual therapy using cognitive-behavioral approaches, and honest communication with the treating medical team all contribute to psychological wellbeing in a genuinely difficult situation.
After Subarachnoid Hemorrhage: The Recovery Road
For survivors of ruptured aneurysm and subarachnoid hemorrhage, recovery is often long and involves challenges that extend well past the acute hospitalization. Understanding the typical recovery trajectory helps survivors and families set realistic expectations and find the right support.
Acute hospitalization for SAH typically runs 2-4 weeks in the ICU, centered on treating the aneurysm itself (clipping or coiling), managing vasospasm, treating hydrocephalus if it’s present, and blood pressure management. The immediate post-treatment window carries significant risk of secondary complications — vasospasm monitoring is intensive, with daily transcranial Doppler studies and frequent neurological exams.
After discharge, most SAH survivors need weeks to months of rehabilitation. Cognitive effects are among the most persistent and disabling of all — even survivors with good neurological outcomes on paper often report memory problems, trouble concentrating, fatigue, and mood disturbances that can persist a year or longer.
A landmark study in Stroke found approximately 50% of SAH survivors had significant cognitive impairment detectable on formal testing at one year — even among those rated as having “good functional outcomes” by standard scales.
Fatigue is almost universal in the first months after SAH, and it’s one of the most common reasons survivors struggle to get back to work and normal life. The brain’s recovery from the initial injury and from vasospasm injury is energy-intensive, and patients genuinely need rest even when their external neurological status looks fine. Pushing through fatigue aggressively in early recovery can slow things down rather than speed them up.
Common Questions About Anatomy Aneurysm Understanding About Aneurysms
Can aneurysms be prevented?
Aneurysm formation can’t be entirely prevented, given how much genetics contributes, but modifiable risk factors account for a large share of population risk. Rigorous blood pressure control, complete smoking cessation, moderate alcohol use, and avoiding cocaine and stimulant drugs substantially cut both the risk of formation and the risk of rupture in those who already have one. For people with hereditary risk factors, these interventions matter even more, paired with surveillance imaging.
Is headache always a warning sign of aneurysm?
No — headaches are extremely common, and the vast majority have nothing to do with an aneurysm. The specific pattern that warrants emergency evaluation is a thunderclap headache: sudden onset, maximum severity within 60 seconds, often “the worst headache of my life,” and qualitatively different from the person’s usual headaches. Gradual-onset headaches, tension-type headaches, typical migraines — none of those carry the same emergency profile. The tell is sudden onset with maximum intensity right from the start.
Who should get screened for aneurysms?
Current guidelines support targeted screening for people with two or more first-degree relatives who’ve had an intracranial aneurysm or subarachnoid hemorrhage, and for patients with autosomal dominant polycystic kidney disease. Anyone with one affected first-degree relative plus additional risk factors (hypertension, smoking) may reasonably bring up screening with their physician. The test is MR angiography — non-invasive, no radiation, roughly 30-45 minutes. Universal population screening isn’t currently recommended, given the cost-benefit math at the population level.
What is the recovery like after aneurysm treatment?
Depends heavily on whether the aneurysm was treated before or after rupture. Electively treated unruptured aneurysms — clipping or coiling — typically involve a hospital stay of several days to a week, with most patients back to normal activity within one to six weeks depending on approach. Recovery after subarachnoid hemorrhage is much more variable and often much longer — months to over a year — with cognitive and fatigue-related challenges lingering even in neurologically intact survivors.
The grade at presentation — the Hunt and Hess scale — is the strongest predictor of recovery trajectory.
Should family members of aneurysm patients get their children tested?
For children, routine screening isn’t generally recommended even in high-risk families, because pediatric intracranial aneurysms are rare, rupture in childhood is exceptionally uncommon, and a positive finding carries a real psychological burden for a child. Most family screening protocols target adults, typically starting in the twenties or thirties for high-risk relatives. The question of when to screen in a hereditary-risk family is best worked out with a neurovascular specialist who can give a personalized risk assessment.
Is a brain aneurysm the same as a stroke?
Not exactly, though an aneurysm rupture causes a specific type of stroke. “Stroke” covers both ischemic stroke, caused by a blockage of blood flow and the most common type at roughly 87% of strokes, and hemorrhagic stroke, caused by bleeding. Subarachnoid hemorrhage from a ruptured aneurysm is a type of hemorrhagic stroke. Aneurysms can also cause ischemic stroke when a clot forms inside the sac and then embolizes downstream, though that’s less common than rupture itself.
Unruptured aneurysms that aren’t bleeding or clotting aren’t strokes and don’t cause acute neurological injury on their own, though they represent a risk for future hemorrhagic stroke.
Recognizing Symptoms and Building Awareness: What Men and Women Need to Know
Aneurysm awareness isn’t just about memorizing warning signs — it’s about building the kind of health literacy that closes the gap between symptom onset and an appropriate emergency response. The statistics on delayed care are sobering: clinical data indicates that patients with subarachnoid hemorrhage who present to the ER with sentinel headaches get misdiagnosed and discharged without evaluation in roughly 12-25% of cases.
The reasons: physician cognitive bias (“it’s probably just a migraine”), institutional time pressure, and patients themselves minimizing their symptoms.
Building real awareness means understanding not just the thunderclap headache pattern but the wider range of symptoms that can accompany or precede an aneurysm rupture. Unruptured aneurysms can occasionally cause symptoms before rupture through mass effect — pressure on nearby structures. A posterior communicating artery aneurysm can compress the third cranial nerve, causing a drooping eyelid and a dilated pupil on the same side that won’t constrict to light — a neuro-ophthalmic emergency in its own right.
Large basilar artery aneurysms can cause brainstem symptoms. Growing unruptured aneurysms can produce local pain at their site. These presentations show up less often than the thunderclap headache of rupture or sentinel bleed, but they’re a secondary warning system that can allow elective treatment before catastrophic hemorrhage.
Family conversations about aneurysm history are significantly underused in families carrying hereditary risk. Where one member has been diagnosed with an intracranial aneurysm or had a subarachnoid hemorrhage, first-degree relatives often don’t know their own risk, or don’t act on it even when they do. Building a family health history — explicitly including aneurysm, SAH, and related conditions — and bringing that history to medical appointments is a concrete step with potentially life-saving weight behind it.
The Brain Aneurysm Foundation provides resources specifically for having these family conversations and for understanding hereditary risk in plain terms.
Geographic and institutional factors affect outcomes substantially. SAH outcomes are markedly better at high-volume cerebrovascular centers — hospitals treating more than 20-25 SAH cases a year show mortality and morbidity rates well below lower-volume centers. The evidence for this volume-outcome relationship is strong: a large national database analysis found SAH patients treated at high-volume centers had approximately 30% lower mortality than those treated at low-volume hospitals.
When a patient presents with SAH and is clinically stable enough for transport, transfer to a high-volume cerebrovascular center with both neurosurgical and endovascular capability should be strongly considered.
Diane, whose story opened this article, eventually became a volunteer educator for the Brain Aneurysm Foundation. In the years after Paul’s death, she visited schools, community centers, and primary care offices, teaching one simple rule: if you or someone near you suddenly develops the worst headache of their life — sudden onset, severe, unlike anything before — call 911 immediately. Don’t drive. Don’t wait. Don’t Google it. Call 911.
She learned that rule too late for Paul. She’s told it to thousands of people since, knowing some fraction of them will one day use it correctly and survive something that Paul didn’t.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map